[DOI] [PubMed] [Google Scholar] 117.Lian H., Guan P., Tan H., Zhang X., Meng Z
They're designed to: Confirm the weight loss and metabolic benefits seen in Phase 2 Identify rare side effects that smaller trials might have missed Demonstrate consistent results across diverse populations (age, sex, ethnicity, comorbidities) Build long-term safety data (cardiovascular outcomes, liver health, kidney function) Provide the evidence package the FDA needs to approve the drug Retatrutide's Phase 2 results were strong enough (up to 24.2% weight loss) that Eli Lilly moved it into a large Phase 3 program
These include metals such as cadmium, mercury, lead, uranium, platinum, and others (Saboli 2006)
I think hes going to be much less radical than you would think, Trump said about Kennedy
Curr Rheumatol Rep 17:22 Janciauskiene S (2020) The beneficial effects of antioxidants in health and diseases
For a deeper look at retatrutides proposed mechanism, see How Retatrutide Works